Cargando…
Fate of TLR-1/TLR-2 agonist functionalised pDNA nanoparticles upon deposition at the human bronchial epithelium in vitro
BACKGROUND: Plasmid DNA vaccination is a promising approach, but studies in non-human primates and humans failed to achieve protective immunity. To optimise this technology further with focus on pulmonary administration, we developed and evaluated an adjuvant-equipped DNA carrier system based on the...
Autores principales: | Heuking, Simon, Rothen-Rutishauser, Barbara, Raemy, David Olivier, Gehr, Peter, Borchard, Gerrit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765319/ https://www.ncbi.nlm.nih.gov/pubmed/23964697 http://dx.doi.org/10.1186/1477-3155-11-29 |
Ejemplares similares
-
Nanocarriers for DNA Vaccines: Co-Delivery of TLR-9 and NLR-2 Ligands Leads to Synergistic Enhancement of Proinflammatory Cytokine Release
por: Poecheim, Johanna, et al.
Publicado: (2015) -
Pulmonary Delivery of Plasmid DNA for Disease Prevention and Therapy
por: Heuking, Simon, et al.
Publicado: (2011) -
Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the "relative deposition index": Evidence for clearance through microvasculature
por: Mühlfeld, Christian, et al.
Publicado: (2007) -
Effects of flame made zinc oxide particles in human lung cells - a comparison of aerosol and suspension exposures
por: Raemy, David O, et al.
Publicado: (2012) -
Co-ordinated Role of TLR3, RIG-I and MDA5 in the Innate Response to Rhinovirus in Bronchial Epithelium
por: Slater, Louise, et al.
Publicado: (2010)